IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q4 2022 Holdings

Filed 2023-02-14 | 5 holdings | $127.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines, Inc.(RVMD)COM76155X100$38.2M1,604,13029.9%
Pliant Therapeutics, Inc.(PLRX)COM729139105$35.6M1,839,16027.9%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$33.1M5,428,93326.0%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$14.3M1,962,20211.2%
Decibel Therapeutics, Inc.COM24343R106$6.4M3,139,6855.0%